Cyberlith IX Implantable Pulse Generator
by Intermedics, Inc. 510(k)
Active
510(k) K801337
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK801337 | Date23 Sep 1981 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- DXY
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3610
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The Cyberlith IX Implantable Pulse Generator is a Class III implantable pacemaker pulse-generator, designed to regulate cardiac rhythm by delivering electrical impulses to the heart. It is intended for patients requiring temporary or permanent pacing support due to bradycardia or other conduction disorders.
This device is implanted subcutaneously and is intended for single-use within the body. It is regulated under FDA 510(k) clearance (K801337) and falls under the classification of an implantable pacemaker pulse-generator (DXY). The device is supplied sterile and requires surgical implantation by a qualified healthcare professional in a controlled clinical setting.
Other devices from Intermedics, Inc.
Questions
AI-generated answers, 18 Sep 2026
What is the Cyberlith IX Implantable Pulse Generator used for in clinical practice?
The Cyberlith IX Implantable Pulse Generator is designed to regulate cardiac rhythm by delivering electrical impulses to the heart. It is intended for patients who require temporary or permanent pacing support due to bradycardia (slow heart rate) or other conduction disorders, ensuring consistent and controlled heartbeats.
Is the Cyberlith IX Implantable Pulse Generator intended for single-use or reusable applications?
The Cyberlith IX Implantable Pulse Generator is explicitly designed for single-use within the body after surgical implantation. It is not intended for reuse or external applications, as it is meant to remain implanted subcutaneously as a permanent or temporary pacing solution.
How is the Cyberlith IX Implantable Pulse Generator supplied, and what are the handling requirements?
The device is supplied sterile and requires surgical implantation by a qualified healthcare professional in a controlled clinical setting. Since it is implanted subcutaneously, it must be handled under sterile conditions to prevent infection and ensure proper functionality.
What regulatory pathway was followed for the Cyberlith IX Implantable Pulse Generator’s approval?
The Cyberlith IX Implantable Pulse Generator was cleared through the FDA 510(k) process (K801337) under the classification of an Implantable Pacemaker Pulse-Generator (DXY). It was reviewed by the Cardiovascular (CV) Advisory Committee and determined to be substantially equivalent to prior devices, with a traditional clearance type.